APLLTD — Alembic Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- IN₹149.41bn
- IN₹161.55bn
- IN₹73.45bn
Brief: Alembic Pharmaceuticals Ltd Incorporates Subsidiary In Philippines
Brief: Alembic Pharmaceuticals Ltd Receives USFDA Final Approval For Methotrexate Injection USP
Brief: Alembic Pharma Gets USFDA Final Approval For Paroxetine Extended-Release Tablets 12.5 Mg
Brief: Alembic Pharmaceuticals Incorporates Subsidiary In Thailand
Brief: Alembic Pharmaceuticals Receives USFDA Final Approval For Efinaconazole Topical Solution, 10%
Drugmaker Alembic Pharma posts earnings dip on Indian labour code changes
Brief: Alembic Pharma Q3 Consol Profit 1.33 Billion Rupees
Brief: Alembic Pharmaceuticals Receives USFDA Final Approval For Difluprednate Emulsion
Brief: Alembic Pharmaceuticals Ltd Announces USFDA Final Approval For Difluprednate Ophthalmic Emulsion, 0.05%
Brief: Alembic Pharmaceuticals Receives USFDA Tentative Approval For Bosutinib Tablets, 400 Mg
Brief: Alembic Pharmaceuticals Gets USFDA Final Approval For Travoprost Ophthalmic Solution
Brief: Alembic Pharmaceuticals Receives USFDA Approval For Dexlansoprazole Capsules
Brief: Alembic Pharmaceuticals Receives USFDA Final Approval For Sumatriptan Injection USP
Aurobindo Pharma's profit rises on steady domestic demand
India's Alembic Pharma posts quarterly profit jump on strong generics demand
Brief: Alembic Pharmaceuticals Receives USFDA Approval For Ticagrelor Tablets, 60 Mg
Brief: Alembic Pharmaceuticals Receives USFDA Approval For Paroxetine Tablets
India's Alembic Pharma gains after US FDA nod for hypertension drug
Brief: Alembic Pharmaceuticals Receives USFDA Final Approval For Macitentan Tablets, 10 Mg